ALT stock · HLT stock

ALT vs HLT · rev $20.0K vs P/E 51, rev $11.17B

Altimmune Inc (ALT) versus Hilton Worldwide Holdings Inc (HLT) — a side-by-side from cached financials, not a winner call.

Altimmune Inc (ALT) is a biotechnology company listed on US.

Hilton Worldwide Holdings Inc (HLT) is a lodging company listed on US.

Latest reported ALT revenue for 2024-12-31 was $20.0K. Net income was -$95.1M. Revenue was down 95.3% from 2023-12-31 to 2024-12-31. ALT currently screens at market cap $527.0M.

Latest reported HLT revenue for 2024-12-31 was $11.17B. Net income was $1.54B. Revenue was up 9.2% from 2023-12-31 to 2024-12-31. HLT currently screens at market cap $75.44B and trailing P/E 50.5.

ALT currently screens at market cap $527.0M. HLT currently screens at market cap $75.44B and trailing P/E 50.5.

Not investment advice. Open the ALT and HLT stock pages for the full models.

Not investment advice.

Popular Stock Comparisons